Search results
Results From The WOW.Com Content Network
Premenstrual syndrome (PMS) is a disruptive set of emotional and physical symptoms that regularly occur in the one to two weeks before the start of each menstrual period. [ 4 ] [ 5 ] Symptoms resolve around the time menstrual bleeding begins. [ 4 ]
Premenstrual dysphoric disorder; Other names: Late luteal phase dysphoric disorder: Specialty: Psychiatry: Symptoms: Severe mood swings, depression, irritability, agitation, uneasiness, change in appetite, severe fatigue, anxiety, anger insomnia/hypersomnia, breast tenderness, decreased interest in usual social activities, reduced interest in sexual activity, difficulty in concentration
Premenstrual syndrome (PMS) or premenstrual tension refers to the emotional and physical symptoms that routinely occur in the two weeks leading up to menstruation. [5] Symptoms are usually mild, but 5-8% of women experience moderate to severe symptoms that significantly affect daily activities. [ 6 ]
This symptom, among others, have been connected to premenstrual syndrome (PMS), which is experienced by women days before their menstrual cycle begins. [2] [3] However, water retention itself can cause symptoms similar to those of PMS like body aches, headaches, and nausea. The actual duration of how long symptoms can last varies in length ...
This cluster of symptoms is often referred to as premenstrual syndrome (PMS). For some individuals, the psychopathological symptoms associated with menstruation can be severe and debilitating, leading to a condition known as premenstrual dysphoric disorder (PMDD). PMDD is characterized by intense mood disturbances, cognitive, and somatic ...
GPnotebook is a British medical database for general practitioners (GPs). [1] It is an online encyclopaedia of medicine that provides an immediate reference resource for clinicians worldwide. The database consists of over 30,000 index terms and over two million words of information.
Symptoms interfere with normal life, qualifying as premenstrual syndrome, in 20–30% of women. In 3–8%, symptoms are severe. [ 8 ] Premenstrual dysphoric disorder (PMDD) is a severe and disabling form of premenstrual syndrome affecting 1.8–5.8% of menstruating women.
Hormonal therapies to reduce or stop menstrual bleeding have long been used to manage a number of gynecologic conditions including menstrual cramps (dysmenorrhea), heavy menstrual bleeding, irregular or other abnormal uterine bleeding, menstrual-related mood changes (premenstrual syndrome or premenstrual dysphoric disorder), and pelvic pain due to endometriosis or uterine fibroids.